{"id":"https://openalex.org/W2114374331","doi":"https://doi.org/10.1146/annurev.pharmtox.011008.145638","title":"The COXIB Experience: A Look in the Rearview Mirror","display_name":"The COXIB Experience: A Look in the Rearview Mirror","publication_year":2008,"publication_date":"2008-10-13","ids":{"openalex":"https://openalex.org/W2114374331","doi":"https://doi.org/10.1146/annurev.pharmtox.011008.145638","mag":"2114374331","pmid":"https://pubmed.ncbi.nlm.nih.gov/18851701"},"language":"en","primary_location":{"id":"doi:10.1146/annurev.pharmtox.011008.145638","doi":"https://doi.org/10.1146/annurev.pharmtox.011008.145638","is_oa":false,"landing_page_url":"https://doi.org/10.1146/annurev.pharmtox.011008.145638","pdf_url":null,"source":{"id":"https://openalex.org/S163849586","display_name":"The Annual Review of Pharmacology and Toxicology","issn_l":"0362-1642","issn":["0362-1642","1545-4304"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-1","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320373","host_organization_name":"Annual Reviews","host_organization_lineage":["https://openalex.org/P4310320373"],"host_organization_lineage_names":["Annual Reviews"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annual Review of Pharmacology and Toxicology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2114374331"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089031929","display_name":"Lawrence J. Marnett","orcid":"https://orcid.org/0000-0002-7834-6285","observed_orcids":["https://orcid.org/0000-0002-7834-6285"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Lawrence J. Marnett","raw_affiliation_strings":["Departments of Biochemistry, Chemistry, and Pharmacology, Vanderbilt Institute of Chemical Biology, Center in Molecular Toxicology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146;","Department of Biochemistry, Vanderbilt Institute of Chemical Biology, Center in Molecular Toxicology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, USA. larry.marnett@vanderbilt.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Biochemistry, Chemistry, and Pharmacology, Vanderbilt Institute of Chemical Biology, Center in Molecular Toxicology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146;","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"Department of Biochemistry, Vanderbilt Institute of Chemical Biology, Center in Molecular Toxicology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, USA. larry.marnett@vanderbilt.edu","institution_ids":["https://openalex.org/I200719446"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5089031929"],"corresponding_institution_ids":["https://openalex.org/I200719446"],"apc_list":null,"apc_paid":null,"fwci":1.5443,"has_fulltext":false,"cited_by_count":235,"citation_normalized_percentile":{"value":0.87242798,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"49","issue":"1","first_page":"265","last_page":"290"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cox-2-inhibitors","display_name":"COX-2 inhibitors","score":0.824999988079071},{"id":"https://openalex.org/keywords/cox-2-selective-inhibitors","display_name":"COX-2 selective inhibitors","score":0.8159999847412109},{"id":"https://openalex.org/keywords/cyclooxygenase","display_name":"cyclooxygenase","score":0.828000009059906},{"id":"https://openalex.org/keywords/cox-1","display_name":"cyclooxygenase-1","score":0.8880000114440918},{"id":"https://openalex.org/keywords/cyclooxygenase-2","display_name":"cyclooxygenase-2","score":0.8569999933242798},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.8899999856948853},{"id":"https://openalex.org/keywords/gastrointestinal-toxicity","display_name":"gastrointestinal toxicity","score":0.9039999842643738},{"id":"https://openalex.org/keywords/adverse-cardiovascular-events","display_name":"cardiovascular adverse events","score":0.9319999814033508},{"id":"https://openalex.org/keywords/colorectal-cancer-prevention","display_name":"colorectal cancer prevention","score":0.7379999756813049},{"id":"https://openalex.org/keywords/colonic-polyps","display_name":"colonic polyps","score":0.7129999995231628},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.7260000109672546},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.41999998688697815}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7505639791488647},{"id":"https://openalex.org/C2779689624","wikidata":"https://www.wikidata.org/wiki/Q410251","display_name":"Cyclooxygenase","level":3,"score":0.5663148164749146},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5612979531288147},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5267671346664429},{"id":"https://openalex.org/C2780820201","wikidata":"https://www.wikidata.org/wiki/Q173235","display_name":"Analgesic","level":2,"score":0.5176544785499573},{"id":"https://openalex.org/C2779703632","wikidata":"https://www.wikidata.org/wiki/Q581996","display_name":"Anti-inflammatory","level":2,"score":0.47892460227012634},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.47764885425567627},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.44278284907341003},{"id":"https://openalex.org/C2777031258","wikidata":"https://www.wikidata.org/wiki/Q377458","display_name":"COX-2 inhibitor","level":4,"score":0.4182780086994171},{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.4111935496330261},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27400028705596924},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008953","descriptor_name":"Models, Anatomic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009626","descriptor_name":"Terminology as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049673","descriptor_name":"History, 20th Century","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":"Q000266","qualifier_name":"history","is_major_topic":true},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1146/annurev.pharmtox.011008.145638","doi":"https://doi.org/10.1146/annurev.pharmtox.011008.145638","is_oa":false,"landing_page_url":"https://doi.org/10.1146/annurev.pharmtox.011008.145638","pdf_url":null,"source":{"id":"https://openalex.org/S163849586","display_name":"The Annual Review of Pharmacology and Toxicology","issn_l":"0362-1642","issn":["0362-1642","1545-4304"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-1","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320373","host_organization_name":"Annual Reviews","host_organization_lineage":["https://openalex.org/P4310320373"],"host_organization_lineage_names":["Annual Reviews"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annual Review of Pharmacology and Toxicology","raw_type":"journal-article"},{"id":"pmid:18851701","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18851701","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annual review of pharmacology and toxicology","raw_type":"Historical Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1509819248","display_name":null,"funder_award_id":"GM 15431","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G2440397094","display_name":"Research Center for Pharmacology and Drug Toxicology","funder_award_id":"P50GM015431","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G2899941542","display_name":"Functional Analysis of Cyclooxygenase-2","funder_award_id":"R01CA089450","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G696513138","display_name":"Detection of Neoplasia in the Esophagus","funder_award_id":"U54CA105296","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":62,"referenced_works":["https://openalex.org/W1591927171","https://openalex.org/W1594307292","https://openalex.org/W1595684975","https://openalex.org/W1597512265","https://openalex.org/W1676314625","https://openalex.org/W1820197413","https://openalex.org/W1876192519","https://openalex.org/W1928411162","https://openalex.org/W1946182096","https://openalex.org/W1975560535","https://openalex.org/W1976365391","https://openalex.org/W1978504750","https://openalex.org/W1980990431","https://openalex.org/W1982248155","https://openalex.org/W1985844039","https://openalex.org/W1987245757","https://openalex.org/W1997364548","https://openalex.org/W1998167638","https://openalex.org/W2008574207","https://openalex.org/W2010830556","https://openalex.org/W2010860405","https://openalex.org/W2011314680","https://openalex.org/W2012920835","https://openalex.org/W2014664456","https://openalex.org/W2020563114","https://openalex.org/W2023887529","https://openalex.org/W2024715019","https://openalex.org/W2030768867","https://openalex.org/W2031652451","https://openalex.org/W2036866147","https://openalex.org/W2038410983","https://openalex.org/W2039358393","https://openalex.org/W2040040765","https://openalex.org/W2040424319","https://openalex.org/W2052364512","https://openalex.org/W2055394727","https://openalex.org/W2055691692","https://openalex.org/W2077459776","https://openalex.org/W2080181436","https://openalex.org/W2083651943","https://openalex.org/W2084863173","https://openalex.org/W2096170866","https://openalex.org/W2096874183","https://openalex.org/W2097235831","https://openalex.org/W2125003309","https://openalex.org/W2126853519","https://openalex.org/W2128680329","https://openalex.org/W2134234269","https://openalex.org/W2134634779","https://openalex.org/W2139776244","https://openalex.org/W2142881330","https://openalex.org/W2145818074","https://openalex.org/W2147339810","https://openalex.org/W2158131645","https://openalex.org/W2158968701","https://openalex.org/W2162364577","https://openalex.org/W2163756514","https://openalex.org/W2167619792","https://openalex.org/W2330496155","https://openalex.org/W2330709704","https://openalex.org/W2416482918","https://openalex.org/W4406964633"],"related_works":["https://openalex.org/W4402830770","https://openalex.org/W2068100830","https://openalex.org/W2371111777","https://openalex.org/W2062719785","https://openalex.org/W2084447650","https://openalex.org/W2396688588","https://openalex.org/W2021218503","https://openalex.org/W2042300117","https://openalex.org/W2109019211","https://openalex.org/W2620844507"],"abstract_inverted_index":{"Non-steroidal":[0],"anti-inflammatory":[1,59],"drugs":[2,13],"(NSAIDs)":[3],"are":[4,130],"among":[5],"the":[6,15,23,27,49,54,58,74,115,139,145,157],"most":[7],"widely":[8],"used":[9],"prescription":[10],"and":[11,36,38,43,60,106,142,154],"nonprescription":[12],"in":[14],"world.":[16],"The":[17,93],"discovery":[18],"of":[19,25,30,33,40,45,63,77,81,121,138,144],"cyclooxygenase":[20],"(COX)":[21],"as":[22],"target":[24,56],"NSAIDs,":[26],"subsequent":[28],"identification":[29],"two":[31],"isoforms":[32],"COX":[34],"(COX-1":[35],"COX-2),":[37],"studies":[39],"their":[41,82],"regulation":[42],"sites":[44],"expression":[46],"led":[47],"to":[48,90,103],"hypothesis":[50,116],"that":[51,68,117,129],"COX-2":[52],"is":[53],"molecular":[55],"for":[57],"analgesic":[61],"effects":[62,76,101,128],"NSAIDs.":[64],"A":[65],"corollary":[66],"was":[67,88],"COX-2-selective":[69],"inhibitors":[70],"(COXIBs)":[71],"would":[72],"retain":[73],"desirable":[75],"NSAIDs":[78,105],"without":[79],"some":[80],"liabilities":[83],"(e.g.,":[84],"gastrointestinal":[85,99],"toxicity,":[86],"which":[87],"ascribed":[89],"COX-1":[91],"inhibition).":[92],"first":[94],"marketed":[95],"COXIBs":[96,118],"exhibited":[97],"reduced":[98],"side":[100],"relative":[102],"traditional":[104],"were":[107],"enormous":[108],"commercial":[109],"successes.":[110],"However,":[111],"clinical":[112],"trials":[113],"testing":[114],"prevent":[119],"recurrence":[120],"premalignant":[122],"colon":[123],"polyps":[124],"uncovered":[125],"adverse":[126],"cardiovascular":[127],"mechanism":[131],"based.":[132],"This":[133],"review":[134],"provides":[135],"an":[136],"overview":[137],"discovery,":[140],"development,":[141],"difficulties":[143],"COXIBs,":[146],"a":[147],"perspective":[148],"on":[149,156],"what":[150],"has":[151],"been":[152],"learned,":[153],"speculation":[155],"way":[158],"forward.":[159]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":15},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":11},{"year":2017,"cited_by_count":16},{"year":2016,"cited_by_count":21},{"year":2015,"cited_by_count":20},{"year":2014,"cited_by_count":17},{"year":2013,"cited_by_count":22},{"year":2012,"cited_by_count":22}],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2016-06-24T00:00:00"}